Vildarise M Tabs

Composition

Vildagliptin 50 mg + Metformin Hydrochloride 500 mg (sustained/extended release) tablet

Uses of Vildarise M Tabs

Type 2 diabetes mellitus: to improve blood glucose control in adults when diet and exercise are not sufficient; used when dual therapy with metformin and a DPP-4 inhibitor is appropriate

• •Lowers fasting and post-meal blood glucose
• •Improves insulin response in a glucose-dependent manner
• •Helps reduce hepatic glucose output
• •Low risk of hypoglycaemia when used without insulin/sulfonylurea
• •Supports long-term HbA1c reduction

How it works

Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), enhancing glucose-dependent insulin release and reducing glucagon. Metformin decreases hepatic glucose production, reduces intestinal glucose absorption, and improves insulin sensitivity, lowering blood sugar levels.

Directions for use

Oral tablet. Take as prescribed, usually once or twice daily with meals to reduce stomach upset (especially due to metformin). Swallow whole; do not crush/chew if SR/ER. Monitor blood glucose regularly and follow diet/exercise advice.

Side effects

Common side effects of Vildarise M Tabs may include:

• •Nausea
• •vomiting
• •diarrhea